Inventors:
Gary A. Cain - Wilmington DE
Reginald O. Cann - Bear DE
Christopher A. Teleha - Bear DE
Denette K. Murphy - Bear DE
Assignee:
Bristol Myers Squibb Pharma Company - Princeton NJ
International Classification:
C07C 6333
Abstract:
This invention pertains to novel salt forms of trophenylethylene compound, such as 3-[4(1,2-diphenyl-but-1-enyl)-phenyl]-acrylic acid, as selective estrogen receptor modulators. This invention also provides methods for the treatment and/or prevention of breast, uterine, ovarian, prostrate and colon cancer, osteoporosis, cardiovascular disease, and benign proliferative disorders, as well as pharmaceutical compositions of the compounds of the present invention.